Amlodipine-induced gingival hyperplasia in chronic renal failure: A case report

African Health Sciences

Volumn 12, Issue 4, 2012, Pages 576-578

  Aldemir, M N ^a   Begenik, H ^a   Emre, H ^a   Erdur, F M ^a   Soyoral, Y ^a  

^a YUZUNCU YIL UNIVERSITY   (Turkey)

Author keywords

Amlodipine; Chronic renal failure; Gingival hyperplasia

Indexed keywords

AMLODIPINE; ANGIOTENSIN RECEPTOR ANTAGONIST; CARVEDILOL;

ADULT; ARTICLE; CASE REPORT; CHRONIC KIDNEY FAILURE; CLINICAL FEATURE; DISEASE CLASSIFICATION; DISEASE DURATION; DISEASE EXACERBATION; DRUG EFFECT; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FOLLOW UP; GINGIVA HYPERPLASIA; HUMAN; HYPERTENSION; MALE; PRESCRIPTION; REMISSION; TREATMENT DURATION;

AMLODIPINE; CHRONIC RENAL FAILURE; GINGIVAL HYPERPLASIA;

ADULT; AMLODIPINE; CALCIUM CHANNEL BLOCKERS; GINGIVAL HYPERPLASIA; HUMANS; HYPERTENSION; KIDNEY FAILURE, CHRONIC; MALE; TREATMENT OUTCOME;

EID: 84873259014     PISSN: 16806905     EISSN: None     Source Type: Journal    
DOI: 10.4314/ahs.v12i4.30     Document Type: Article

References (13)

1. Abernethy DR. The pharmacokinetic profile of amlodipine. Am Heart J. 1989 Nov; 118(5 Pt 2): 1100-1103.
2. Ellis JS, Seymour RA, Thomason JM, Monkman SC, Idle JR: Gingival sequestration of amlodipine induced gingival overgrowth. Lancet 1993; 341: 1102-1103.
3. Jorgensen MG: Prevalence of amlodipine related gingival hyperplasia. J Periodontol 1997; 68: 678
4. Ellis JS, Seymour RA, Steele JG, Robertson P, Butler TJ, Thomason JM: Prevalence of gingival over-growth induced by calcium channel blockers: a community-based study. J Periodontol 1997; 0: 63-67.
5. Miller CS, Damm DD. Incidence of verapamilinduced gingival hyperplasia in a dental population. J Periodontol. 1992 May; 63(5): 453-456.
6. Ono M, Tanaka S, Takeuchi R, Matsumoto H, Okada H, Yamamoto H, Makiyama Y, Hirayama T, Sakamaki T, Fujii A, Akimoto Y: Prevelance of amlodipine-induced gingival overgrowth. Int J Oral- Med Sci 2010; 9(2): 96-100.
7. Meraw SJ, Sheridan PJ: Medically induced gingival hyperplasia. Mayo Clin Proc 1998; 73: 1196-1199
8. Matharu MS, Van Vilet JA, Ferrari MD, Goadsby PJ. Verapamil induced gingival enlargement in cluster headache. J Neural Neurosurg Psychiatry 2005; 76: 124-127.
9. Gregoriou A, Schneider P: Phenobarbitalinduced gingival overgrowth? Report of two cases and complications in management. ASDC J Dent Child 1996; 63: 408-413.
10. Lafzi A, Farahani RMZ, Shoja MM: Amlodipine-induced gingival hyperplasia. Med Oral Patol Oral Cir Bucal 2006; 11: 480-482
11. Tavassoli S, Yamalik N, Caglayan F, Caglayan G, Eratalay K: The clinical effects of nifedipine on periodontal status. J Periodontol 1998; 69: 108-112.
12. Camargo PM, Melnick PR, Pirih FQ, Lagos R, Takei HH. Treatment of drug-induced gingival enlargement: aesthetic and functional considerations. Periodontology 2000; 27: 131-138
13. Hallmon WW, Rossmann JA: The role of drugs in the pathogenesis of gingival overgrowth. A collevtive review of current concepts. Periodontol 2000; 21: 176-196.